Noile-Immune Biotech (TSE:4893) Other Long Term Assets : 円61.4 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Other Long Term Assets?

Noile-Immune Biotech's other long-term assets for the quarter that ended in Mar. 2024 was 円61.4 Mil.

Noile-Immune Biotech's quarterly other long-term assets declined from Sep. 2023 (円62.5 Mil) to Dec. 2023 (円61.9 Mil) but then stayed the same from Dec. 2023 (円61.9 Mil) to Mar. 2024 (円61.4 Mil).

Noile-Immune Biotech's annual other long-term assets increased from Dec. 2021 (円45.7 Mil) to Dec. 2022 (円56.8 Mil) and increased from Dec. 2022 (円56.8 Mil) to Dec. 2023 (円61.9 Mil).

Noile-Immune Biotech Other Long Term Assets Historical Data

The historical data trend for Noile-Immune Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Other Long Term Assets Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

15.18

45.68

56.85

61.86

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial				-	61.93	62.46	61.86	61.44

Noile-Immune Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines